Skip to search formSkip to main contentSkip to account menu

fenofibric acid 45 MG Delayed Release Oral Capsule [Trilipix]

Known as: FENOFIBRIC ACID 45 mg ORAL CAPSULE, DELAYED RELEASE [Trilipix], Trilipix 45 MG (as choline fenofibrate) Delayed Release Oral Capsule, Trilipix 45 MG Delayed Release Oral Capsule 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BackgroundMonotherapy with lipid-modifying medication is frequently insufficient to normalize lipid abnormalities in patients… 
2009
2009
AstraZeneca is to co-promote Abbott’s Trilipix® (fenofibric acid) for the treatment of lipid disorders, which will increase the…